- Report
- March 2025
- 367 Pages
Global
From €5204EUR$6,135USD£4,350GBP
- Report
- February 2025
- 454 Pages
Global
From €4213EUR$4,799USD£3,645GBP
- Report
- January 2026
- 190 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 195 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 187 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 190 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 194 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 182 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 183 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 191 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 190 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 199 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 184 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 187 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- August 2025
- 193 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- March 2025
- 120 Pages
Global
From €4302EUR$4,900USD£3,722GBP
- Report
- December 2025
- 196 Pages
Global
From €4302EUR$4,900USD£3,722GBP
- Report
- November 2025
- 189 Pages
Global
From €4302EUR$4,900USD£3,722GBP
- Report
- February 2026
- 172 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 372 Pages
Global
From €5136EUR$5,850USD£4,443GBP

Biologics Development is a field of drug discovery that focuses on the development of biopharmaceuticals, which are drugs derived from living organisms. This includes proteins, peptides, nucleic acids, and other molecules. The process of biologics development involves the identification of a target molecule, the design of a drug to interact with the target, and the production of the drug. The development of biologics requires a deep understanding of the biology of the target molecule, as well as the ability to produce the drug in a cost-effective manner.
Biologics Development is a rapidly growing field, with many companies investing in the development of new biopharmaceuticals. Companies such as Amgen, Biogen, Genentech, and Novartis are leading the way in the development of biologics. Other companies such as AbbVie, AstraZeneca, and Merck are also investing in the development of biologics. These companies are working to develop new treatments for a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Show Less Read more